T0	ENHANCER 412 427	distal enhancer
T1	PROMOTER 815 836	ATAD2 promoter region
T2	GENE 27 44	androgen receptor
N0	Reference T2 EntrezGene:367	AR
T3	GENE 49 53	E2F1
N1	Reference T3 EntrezGene:1869	2F1
T4	GENE 175 180	ATAD2
N2	Reference T4 EntrezGene:29028	ATAD2
T5	GENE 229 234	ATAD2
N3	Reference T5 EntrezGene:29028	ATAD2
T6	GENE 259 276	androgen receptor
N4	Reference T6 EntrezGene:367	AR
T7	GENE 278 280	AR
N5	Reference T7 EntrezGene:367	AR
T8	GENE 290 293	MYC
N6	Reference T8 EntrezGene:4609	MYC
T9	GENE 318 323	ATAD2
N7	Reference T9 EntrezGene:29028	ATAD2
T10	GENE 360 362	AR
N8	Reference T10 EntrezGene:367	AR
T12	GENE 488 492	E2F1
N10	Reference T12 EntrezGene:1869	2F1
T13	GENE 613 615	AR
N11	Reference T13 EntrezGene:367	AR
T14	GENE 620 624	E2F1
N12	Reference T14 EntrezGene:1869	2F1
T17	DISEASE 972 987	prostate cancer
T18	DISEASE 1035 1040	tumor
T20	GENE 1197 1202	ATAD2
N17	Reference T20 EntrezGene:29028	ATAD2
T24	TISSUE 125 139	prostate cells
T25	TISSUE 213 227	prostate cells
A2	REGION T0 INSUFFICIENT
A1	REGION T1 INSUFFICIENT
A3	CANCER T17
A4	CANCER T18
T11	TFBS 370 427	AR binding sequence (ARBS) located in the distal enhancer
A5	REGION T11 INSUFFICIENT
T15	TFBS 849 853	ARBS
A7	REGION T15 INSUFFICIENT
T16	TFBS 858 875	E2F1 binding site
A9	REGION T16 INSUFFICIENT
T21	TFBS 1061 1065	ARBS
A11	REGION T21 INSUFFICIENT
T19	TFBS 1073 1090	E2F1 binding site
A13	REGION T19 INSUFFICIENT
N9	Reference T24 BTO:0001019	prostate gland cell line
N13	Reference T25 BTO:0001019	prostate gland cell line
N14	Reference T17 MONDO:MONDO:0008315	prostate cancer
T22	GENE 815 820	ATAD2
N15	Reference T22 EntrezGene:29028	ATAD2
T23	GENE 370 372	AR
N16	Reference T23 EntrezGene:367	AR
T26	GENE 858 862	E2F1
N18	Reference T26 EntrezGene:1869	E2F1
T27	GENE 1073 1077	E2F1
N19	Reference T27 EntrezGene:1869	E2F1
N20	Reference T18 MONDO:MONDO:0005070	neoplasm
